Norwegian Institute of Public Health
fhi.noLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
51
Active
12
Phase 3
0
Total enrollment
8,487,865
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- COVID-195
- Breast Cancer4
- Respiratory Tract Infections3
- Mental Disorders2
- Substance Use Disorders2
- Treatment2
- Participation2
- Breast Neoplasms2
Frequently asked questions about Norwegian Institute of Public Health
- How many clinical trials does Norwegian Institute of Public Health have on ClinicalTrials.gov?
- Norwegian Institute of Public Health is listed as the lead sponsor on 51 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Norwegian Institute of Public Health's trials are in Phase 3?
- 0 of Norwegian Institute of Public Health's trials are in Phase 3.
- What therapeutic areas does Norwegian Institute of Public Health focus on?
- Norwegian Institute of Public Health's most-studied conditions on ClinicalTrials.gov are COVID-19, Breast Cancer, Respiratory Tract Infections, Mental Disorders, Substance Use Disorders.